BI 144807

DRUG4 trials

Sponsors

Boehringer Ingelheim

Conditions

AsthmaHealthyWet Macular Degeneration

Phase 1

Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers

CompletedNCT01480648

Boehringer IngelheimHealthy

Start: 2011-11-30Updated: 2013-11-01

Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients

CompletedNCT01651598

Boehringer IngelheimAsthma, Healthy

Start: 2012-07-31End: 2013-01-31Updated: 2013-11-01

Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers

CompletedNCT01707940

Boehringer IngelheimHealthy

Start: 2012-10-31End: 2012-12-31Updated: 2013-05-16

Phase 2

A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration

CompletedNCT02121522

Boehringer IngelheimWet Macular Degeneration

Start: 2014-06-30End: 2015-04-30Updated: 2016-06-27